Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Parathyroid hormone and bone quality].

Masako Ito1

  • 1Division of Radiology, Nagasaki University Hospital.

Clinical Calcium
|December 3, 2005
PubMed
Summary

Intermittent parathyroid hormone (PTH) administration enhances bone quality by improving bone structure and mass. This leads to increased bone strength and reduced fracture risk, independent of bone mineral density alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electroconvulsive Therapy Under Mechanical Ventilation for Catatonia-associated Respiratory Failure.

The journal of ECT·2025
Same author

Emilin2 marks the target region for mesenchymal cell accumulation in bone regeneration.

Inflammation and regeneration·2024
Same author

Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis.

Annals of palliative medicine·2023
Same author

Inhibition of calcium/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis.

Rheumatology (Oxford, England)·2022
Same author

Efficacy and Safety of Naldemedine for Patients with Cancer with Opioid-Induced Constipation in Clinical Practice: A Real-World Retrospective Study.

Journal of clinical medicine·2022
Same author

Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study.

Medicina (Kaunas, Lithuania)·2021

Area of Science:

  • Bone biology and skeletal health.
  • Endocrinology and metabolic bone diseases.

Context:

  • Bone quality, encompassing microarchitecture, turnover, and mineralization, is critical for fracture risk.
  • Bone mineral density alone does not fully correlate with fracture risk reduction.

Purpose:

  • To evaluate the impact of intermittent parathyroid hormone (PTH) administration on bone quality and strength.
  • To elucidate the mechanisms by which PTH influences bone structure and reduces fracture risk.

Summary:

  • Intermittent PTH administration stimulates bone formation and improves bone microarchitecture, including trabecular connectivity and cortical thickness.
  • Preclinical and clinical studies demonstrate that PTH increases total skeletal mass and enhances bone structure.
  • These structural improvements contribute to increased bone strength and a reduced risk of fractures.

Impact:

  • Highlights the importance of bone quality beyond bone mineral density for fracture prevention.
  • Suggests intermittent PTH as a therapeutic strategy for improving skeletal integrity and reducing osteoporotic fractures.

Related Experiment Videos